– UK, Hertfordshire – Britvic plc (LON: BVIC) today announced the appointment of Hounaïda Lasry to its Board as an Independent Non-Executive Director effective from 29 September 2022.
“We are delighted to welcome Hounaïda to the Board. With an extensive and wide-ranging background in consumer goods across Africa, Asia, Europe and the Middle East, Hounaïda’s experience will prove invaluable to Britvic’s continued success. We look forward to her insights on working across markets and cultures and how these can be applied to our portfolio of 37 much-loved brands sold in more than 100 countries.” said Board Chair,am, John Daly.
Hounaïda Lasry will also join the Nomination and Remuneration Committees.
About Hounaïda Lasry
Her executive career has been at Procter and Gamble, where she has held a series of local, regional, and global roles over a significant tenure. She has worked across several geographies and consumer sectors, gaining multi-faceted experience in marketing, operational and corporate roles. Most recently she has been SVP, Skin & Personal Care, Europe, India, Middle East, and Africa. She also served, for five years, on the non-profit Advisory Board of the Geneva School of Economics and Management, at the University of Geneva.
In 2017, Hounaïda Lasry attended the Business and Sustainability Executive Programme at the University of Cambridge and was subsequently tasked with driving ESG integration into plans across the business. Hounaïda, who was born in Morocco, has a degree in Marketing and International Trade from the École Supérieure de Commerce de Chambéry and an MBA from Université Pierre Mendès-France.
For more information: https://www.britvic.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.